WARREN, N.J., Oct. 30, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced that management will present at the Stifel 2018 Healthcare Conference to be held in New York, NY on November 13 and 14.

Aquestive will present on Tuesday, November 13 at 4:15 p.m. Eastern Time. A webcast of the presentation will be available on the "Investors" section of the IR website. For more information, please visit investors.aquestive.com.

About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics has a late-stage proprietary product pipeline focused on the treatment of CNS diseases, and is working to advance orally-administered complex molecules that it believes can be alternatives to invasively-administered standard of care therapies. As the leader in developing and delivering drugs via its PharmFilm® technology, Aquestive Therapeutics also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.

Media inquiries:
Christopher Hippolyte
christopher.hippolyte@syneoshealth.com
212-364-0458

Investor inquiries:
Stephanie Carrington
stephanie.carrington@icrinc.com
646-277-1282

View original content to download multimedia:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-the-stifel-2018-healthcare-conference-300739952.html

SOURCE Aquestive Therapeutics